Cargando…
Application of neoadjuvant chemotherapy in occult breast cancer: Five case reports
RATIONALE: Although rare, occult breast cancer (OBC) originates from breast tissue. Its primary lesions cannot be identified by clinical examination or imaging; therefore, the diagnosis, treatment, and prognosis remain controversial. PATIENT CONCERNS: This study comprised 5 female OBC patients who w...
Autores principales: | Yang, Haisong, Li, Ling, Zhang, Mengmeng, Zhang, Shiyong, Xu, Shu, Ma, Xiaoxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738007/ https://www.ncbi.nlm.nih.gov/pubmed/28984771 http://dx.doi.org/10.1097/MD.0000000000008200 |
Ejemplares similares
-
Anemia and thrombocytopenia as initial symptoms of occult breast cancer with bone marrow metastasis: A case report
por: Liu, Lulu, et al.
Publicado: (2017) -
Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review
por: Xu, Ruixin, et al.
Publicado: (2017) -
Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
por: Tao, Miaomiao, et al.
Publicado: (2017) -
Neoadjuvant chemotherapy combined with endocrine therapy for hormone receptor-positive breast cancer: A systematic review and meta-analysis
por: Ma, Hong-Fang, et al.
Publicado: (2023) -
Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population
por: Wang, Jiayu, et al.
Publicado: (2016)